Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Nov 17, 2026
TickeronGET DAILY SIGNALS
FMC vs NTR: Contrasting Crop Protection with Integrated Nutrition

FMC vs NTR: Contrasting Crop Protection with Integrated Nutrition

Key Takeaways

  • FMC and Nutrien both operate in agriculture, but they sit on opposite sides of the input spectrum: FMC focuses on crop protection chemicals, while Nutrien spans fertilizer production and agricultural retail.
  • Nutrien has delivered record fertilizer volumes and rising earnings, whereas FMC is in the middle of a restructuring that has pressured revenue and forced a steep dividend cut.
  • Relative momentum favors Nutrien, whose shares have outperformed the broader industry over the past year, while FMC has faced downward price pressure and persistent generic competition.
  • Balance-sheet positioning differs sharply: Nutrien is reducing leverage and returning cash to shareholders, while FMC is prioritizing debt reduction after cutting its payout.
  • Tickeron AI Verdict: Nutrien (NTR) — based on observable trend consistency, earnings momentum, and relative stability, the AI currently favors NTR over FMC.
  • For deeper context, explore FMC Major News and FMC Today's Price Move, as well as NTR Major News and NTR Today's Price Move.
  • To see which automated strategies are performing best right now, browse the Trending AI Robots.

Why This Comparison Matters

Investors evaluating the agriculture sector often weigh two distinct business models: pure-play crop protection and diversified crop nutrition. FMC, a global agricultural sciences company, develops and sells insecticides, herbicides, and fungicides. NTR — Nutrien Ltd. — is the world's largest provider of crop inputs and services, producing potash, nitrogen, and phosphate while operating a vast retail network. This stock comparison is relevant for investors assessing relative performance, market positioning, and how each company is navigating the current pricing environment. While both face agricultural cyclicality, their recent trajectories have diverged considerably. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

FMC's Position and Recent Challenges

FMC operates as a focused agricultural sciences firm, generating revenue primarily from crop protection chemicals sold across Latin America, North America, Europe, and Asia. Recent market activity has been challenging. The company has reported sharp revenue declines tied partly to one-time commercial actions as it prepares its India business for sale, alongside a formal impairment charge. Management has also moved to redesign its manufacturing footprint, exiting higher-cost plants to better compete with generics.

Sentiment has been pressured by generic pricing competition, particularly in Latin America, and constrained customer credit in Brazil and Argentina. In response, FMC cut its quarterly dividend by more than 85% and amended its credit agreement, reflecting an emphasis on deleveraging a balance sheet carrying over $4 billion in net debt. These steps signal a company in transition, with near-term catalysts centered on restructuring execution and cost takeout rather than top-line growth.

Nutrien's Stronger Momentum

NTR, or Nutrien Ltd., is a Canadian agriculture and fertilizer company with an integrated model that combines large-scale production of potash, nitrogen, and phosphate with a global retail network serving growers. Its recent performance has been comparatively strong. Nutrien achieved record fertilizer sales volumes, with adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) rising double digits and net earnings improving sharply versus the prior year.

The company has executed a portfolio-simplification strategy, divesting non-core assets including its Profertil stake, and has surpassed its cost-savings targets ahead of schedule. Management has also increased cash returned to shareholders through share repurchases while maintaining its dividend. Analysts have responded with generally constructive ratings, and the shares have gained significantly over the past year, outpacing the broader industry. These factors point to firmer underlying momentum and a healthier earnings trajectory.

Head-to-Head Insights

The contrast between these two companies is pronounced. FMC is a concentrated crop protection pure play, giving it exposure to innovation cycles but also leaving it more vulnerable to generic erosion and regional credit stress. NTR benefits from diversification across potash, nitrogen, phosphate, and retail, which smooths cyclical swings and supports steadier cash generation.

Growth drivers also differ. FMC's story now hinges on cost restructuring, manufacturing consolidation, and new active-ingredient launches, while Nutrien's is built on strong global fertilizer demand, record volumes, and disciplined capital returns. On risk, FMC carries higher leverage and reduced financial flexibility after its dividend cut, whereas Nutrien has been lowering debt and repurchasing shares. Sector exposure adds another layer: FMC leans toward chemicals and innovation, while Nutrien reflects global nutrient fundamentals and commodity pricing. On balance, recent momentum and market sentiment clearly favor Nutrien. From what I see, the earnings trajectory for NTR stands out in this environment.

Tickeron AI Verdict

Based on observable factors — trend consistency, earnings momentum, balance-sheet positioning, and relative stability — Tickeron's AI would currently favor NTR over FMC. Nutrien's record volumes, improving profitability, and shareholder returns suggest a more durable positive trend, while FMC remains in a restructuring phase with revenue headwinds and a recent dividend reduction. The AI's preference is expressed in probabilistic terms, reflecting the stronger relative positioning and steadier momentum currently associated with Nutrien rather than any guaranteed outcome. I'm watching this closely as the sector evolves.

Enhancing Research with AI Tools

In my ongoing analysis of stocks like FMC and NTR, I often rely on Tickeron’s AI Trend Prediction Engine to gauge momentum and consistency. It provides an additional layer of data-driven insight that complements traditional research. If you're looking to enhance your own process, it's worth a look.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FMC, NTR

FMC's RSI Oscillator recovers from oversold territory

The RSI Indicator for FMC moved out of oversold territory on October 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 21 of the 34 cases the stock moved higher. This puts the odds of a move higher at 62%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for FMC just turned positive on October 30, 2026. Looking at past instances where FMC's MACD turned positive, the stock continued to rise in 29 of 47 cases over the following month. The odds of a continued upward trend are 62%.

Following a +3.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where FMC advanced for three days, in 173 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.

FMC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FMC as a result. In 60 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

The Aroon Indicator for FMC entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.535) is normal, around the industry mean (-0.492). P/E Ratio (-0.256) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (1.532) is also within normal values, averaging (0.867). Dividend Yield (0.057) settles around the average of (0.113) among similar stocks. P/S Ratio (0.416) is also within normal values, averaging (1.476).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. FMC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

Notable companies

The most notable companies in this group are CF Industries Holding (NYSE:CF), Mosaic Company (The) (NYSE:MOS).

Industry description

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

Market Cap

The average market capitalization across the Chemicals: Agricultural Industry is 6.12B. The market cap for tickers in the group ranges from 611 to 34.11B. NTR holds the highest valuation in this group at 34.11B. The lowest valued company is BHILQ at 611.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Agricultural Industry was -12%. For the same Industry, the average monthly price growth was -15%, and the average quarterly price growth was -27%. SMG experienced the highest price growth at -2%, while CTVA experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Agricultural Industry was 40%. For the same stocks of the Industry, the average monthly volume growth was -22% and the average quarterly volume growth was 51%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 50
Price Growth Rating: 64
SMR Rating: 80
Profit Risk Rating: 84
Seasonality Score: -32 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of industrial, specialty and agricultural chemicals

Industry ChemicalsAgricultural

Industry
Chemicals Agricultural
Address
2929 Walnut Street
Phone
+1 215 299-6000
Employees
5500
Web
https://www.fmc.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.